| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |